NCT06193174View on ClinicalTrials.gov

Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

August 14, 2026

Study Completion Date

August 14, 2027

Conditions
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of BrainAnaplastic Astrocytoma of Brain
Interventions
DRUG

C134 Re-Administration

Administration of a second dose of C134 to participants that have completed the study Trial of C134 in Patients With Recurrent GBM (C134-HSV-1).

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER